A hallucinogen formerly used as a veterinary anesthetic, and briefly as a general anesthetic for humans. Phencyclidine is similar to KETAMINE in structure and in many of its effects. Like ketamine, it can produce a dissociative state. It exerts its pharmacological action through inhibition of NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE). As a drug of abuse, it is known as PCP and Angel Dust.
Specific sites or molecular structures on cell membranes or in cells with which phencyclidine reacts or to which it binds to elicit the specific response of the cell to phencyclidine. Studies have demonstrated the presence of multiple receptor sites for PCP. These are the PCP/sigma site, which binds both PCP and psychotomimetic opiates but not certain antipsychotics, and the PCP site, which selectively binds PCP analogs.
The misuse of phencyclidine with associated psychological symptoms and impairment in social or occupational functioning.
Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise.
An opioid analgesic with actions and uses similar to MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1095)
A potent noncompetitive antagonist of the NMDA receptor (RECEPTORS, N-METHYL-D-ASPARTATE) used mainly as a research tool. The drug has been considered for the wide variety of neurodegenerative conditions or disorders in which NMDA receptors may play an important role. Its use has been primarily limited to animal and tissue experiments because of its psychotropic effects.
Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists.
A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent.
Venoms produced by frogs, toads, salamanders, etc. The venom glands are usually on the skin of the back and contain cardiotoxic glycosides, cholinolytics, and a number of other bioactive materials, many of which have been characterized. The venoms have been used as arrow poisons and include bufogenin, bufotoxin, bufagin, bufotalin, histrionicotoxins, and pumiliotoxin.
A family of tricyclic hydrocarbons whose members include many of the commonly used tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC).
A class of cell surface receptors recognized by its pharmacological profile. Sigma receptors were originally considered to be opioid receptors because they bind certain synthetic opioids. However they also interact with a variety of other psychoactive drugs, and their endogenous ligand is not known (although they can react to certain endogenous steroids). Sigma receptors are found in the immune, endocrine, and nervous systems, and in some peripheral tissues.
The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
Cell surface receptors that bind signalling molecules released by neurons and convert these signals into intracellular changes influencing the behavior of cells. Neurotransmitter is used here in its most general sense, including not only messengers that act to regulate ion channels, but also those which act on second messenger systems and those which may act at a distance from their release sites. Included are receptors for neuromodulators, neuroregulators, neuromediators, and neurohumors, whether or not located at synapses.
A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
A class of ionotropic glutamate receptors characterized by affinity for N-methyl-D-aspartate. NMDA receptors have an allosteric binding site for glycine which must be occupied for the channel to open efficiently and a site within the channel itself to which magnesium ions bind in a voltage-dependent manner. The positive voltage dependence of channel conductance and the high permeability of the conducting channel to calcium ions (as well as to monovalent cations) are important in excitotoxicity and neuronal plasticity.
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus.
A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
A complex involuntary response to an unexpected strong stimulus usually auditory in nature.
Psychotic organic mental disorders resulting from the toxic effect of drugs and chemicals or other harmful substance.
An analgesic with mixed narcotic agonist-antagonist properties.
The rostral part of the frontal lobe, bounded by the inferior precentral fissure in humans, which receives projection fibers from the MEDIODORSAL NUCLEUS OF THE THALAMUS. The prefrontal cortex receives afferent fibers from numerous structures of the DIENCEPHALON; MESENCEPHALON; and LIMBIC SYSTEM as well as cortical afferents of visual, auditory, and somatic origin.
Drugs obtained and often manufactured illegally for the subjective effects they are said to produce. They are often distributed in urban areas, but are also available in suburban and rural areas, and tend to be grossly impure and may cause unexpected toxicity.
A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
Flavoring agent and non-nutritive sweetener.
Unsaturated azacyclopropane compounds that are three-membered heterocycles of a nitrogen and two carbon atoms.
Detection of drugs that have been abused, overused, or misused, including legal and illegal drugs. Urine screening is the usual method of detection.
Relatively invariant mode of behavior elicited or determined by a particular situation; may be verbal, postural, or expressive.
Dioxolanes are specific chemical compounds characterized by a saturated six-membered ring containing two oxygen atoms and two carbon atoms, often formed through the reaction between aldehydes or ketones and diols, and significant in pharmaceutical synthesis and organic chemistry.
A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
Family in the order COLUMBIFORMES, comprised of pigeons or doves. They are BIRDS with short legs, stout bodies, small heads, and slender bills. Some sources call the smaller species doves and the larger pigeons, but the names are interchangeable.
A schedule prescribing when the subject is to be reinforced or rewarded in terms of temporal interval in psychological experiments. The schedule may be continuous or intermittent.
A genus of the Torpedinidae family consisting of several species. Members of this family have powerful electric organs and are commonly called electric rays.
The physical activity of a human or an animal as a behavioral phenomenon.
The relationship between the dose of an administered drug and the response of the organism to the drug.
An amino acid that, as the D-isomer, is the defining agonist for the NMDA receptor subtype of glutamate receptors (RECEPTORS, NMDA).
Morphine derivatives of the methanobenzazocine family that act as potent analgesics.
A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company.
The observable response an animal makes to any situation.
A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The drug also improves the subjective quality of sleep and decreases portal pressure.
A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
In about 250 species of electric fishes, modified muscle fibers forming disklike multinucleate plates arranged in stacks like batteries in series and embedded in a gelatinous matrix. A large torpedo ray may have half a million plates. Muscles in different parts of the body may be modified, i.e., the trunk and tail in the electric eel, the hyobranchial apparatus in the electric ray, and extrinsic eye muscles in the stargazers. Powerful electric organs emit pulses in brief bursts several times a second. They serve to stun prey and ward off predators. A large torpedo ray can produce of shock of more than 200 volts, capable of stunning a human. (Storer et al., General Zoology, 6th ed, p672)

Effects of stimulants of abuse on extrapyramidal and limbic neuropeptide Y systems. (1/421)

Neuropeptide Y (NPY), an apparent neuromodulating neuropeptide, has been linked to dopamine systems and dopamine-related psychotic disorders. Because of this association, we determined and compared the effects of psychotomimetic drugs on extrapyramidal and limbic NPY systems. We observed that phencyclidine, methamphetamine (METH), (+)methylenedioxymethamphetamine (MDMA), and cocaine, but not (-)MDMA, similarly reduced the striatal content of NPY-like immunoreactivity from 54% (phencyclidine) to 74% [(+) MDMA] of control. The effects of METH on NPY levels in the nucleus accumbens, caudate nucleus, globus pallidus, and substantia nigra were characterized in greater detail. We observed that METH decreased NPY levels in specific regions of the nucleus accumbens and the caudate, but had no effect on NPY in the globus pallidus or the substantia nigra. The dopamine D1 receptor antagonist SCH-23390 blocked these effects of METH, suggesting that NPY levels throughout the nucleus accumbens and the caudate are regulated through D1 pathways. The D2 receptor antagonist eticlopride did not appear to alter the METH effect, but this was difficult to determine because eticlopride decreased NPY levels by itself. A single dose of METH was sufficient to lower NPY levels, in some, but not all, regions examined. The effects on NPY levels after multiple METH administrations were substantially greater and persisted up to 48 h after treatment; this suggests that synthesis of this neuropeptide may be suppressed even after the drug is gone. These findings suggest that NPY systems may contribute to the D1 receptor-mediated effects of the psychostimulants.  (+info)

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. (2/421)

Administration of noncompetitive NMDA/glutamate receptor antagonists, such as phencyclidine (PCP) and ketamine, to humans induces a broad range of schizophrenic-like symptomatology, findings that have contributed to a hypoglutamatergic hypothesis of schizophrenia. Moreover, a history of experimental investigations of the effects of these drugs in animals suggests that NMDA receptor antagonists may model some behavioral symptoms of schizophrenia in nonhuman subjects. In this review, the usefulness of PCP administration as a potential animal model of schizophrenia is considered. To support the contention that NMDA receptor antagonist administration represents a viable model of schizophrenia, the behavioral and neurobiological effects of these drugs are discussed, especially with regard to differing profiles following single-dose and long-term exposure. The neurochemical effects of NMDA receptor antagonist administration are argued to support a neurobiological hypothesis of schizophrenia, which includes pathophysiology within several neurotransmitter systems, manifested in behavioral pathology. Future directions for the application of NMDA receptor antagonist models of schizophrenia to preclinical and pathophysiological research are offered.  (+info)

Effects of (+)-HA-966, CGS-19755, phencyclidine, and dizocilpine on repeated acquisition of response chains in pigeons: systemic manipulation of central glycine sites. (3/421)

The effects of i.m. injections of (+)-HA-966, a glycine-site antagonist at the N-methyl-D-aspartate (NMDA) subtype of the glutamate receptor, its enantiomer (-)-HA-966, the competitive glutamate antagonist CGS-19755, the uncompetitive glutamate antagonists phencyclidine and dizocilpine, and the micro opioid agonist morphine were evaluated in a repeated acquisition task in pigeons. All of the drugs produced dose-dependent decreases in rates of responding. The NMDA receptor and channel blockers and (+)-HA-966 appeared to have a greater effect on acquisition than did morphine at doses that did not fully suppress responding. The rate suppression and learning impairment produced by a large dose of (+)-HA-966 (100 mg/kg) were completely prevented by coadministration of the glycine-site agonist D-serine (560 mg/kg) but not by its enantiomer, L-serine (1000 mg/kg). D-Serine, however, produced incomplete antagonism of the effects of dizocilpine and phencyclidine and failed to alter those of CGS-19755. These findings provide evidence that reducing the activity of the NMDA subtype of the glutamate receptor through pharmacological action at any of three sites produces similar decrements in acquisition, and those produced through antagonism of the glycine site are differentially sensitive to the glycine-site agonist D-serine.  (+info)

Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine. (4/421)

Repeated exposure of rats to the psychotomimetic drug phencyclidine (PCP) markedly increased the response of prefrontal cortical neurons to the glutamate agonist N-methyl-D-aspartate (NMDA) relative to agonist alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid. Moreover, acute challenge by PCP produced a significantly reduced block of NMDA-induced current. In addition, the subchronic administration of PCP reduced significantly the paired-pulse facilitation, accompanied by a significant increase of excitatory postsynaptic current variance. These results suggest that repeated exposure to PCP increased evoked release of excitatory amino acids. The enhanced release of excitatory amino acids evoked by NMDA could explain, at least partly, a hypersensitive response to NMDA and a reduced blockade of the NMDA responses by a PCP challenge in rats exposed repeatedly to PCP. Pretreatment with the atypical antipsychotic drug clozapine, but not the typical antipsychotic drug haloperidol, attenuates the repeated PCP-induced effect. Our results support the hypothesis that clozapine may facilitate NMDA receptor-mediated neurotransmission to improve schizophrenic-negative symptoms and cognitive dysfunction. This novel approach is useful for evaluating the cellular mechanisms of action of atypical antipsychotic drugs.  (+info)

Rat strain differences in the ability to disrupt sensorimotor gating are limited to the dopaminergic system, specific to prepulse inhibition, and unrelated to changes in startle amplitude or nucleus accumbens dopamine receptor sensitivity. (5/421)

Previous studies indicate that a variety of pharmacological agents interfere with the prepulse inhibition of the acoustic startle (PPI) response including phencyclidine (PCP), 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), amphetamine, and apomorphine. Strain differences have been observed in the ability of apomorphine to disrupt PPI, although the degree to which these strain differences occur after administration of nondopaminergic drugs or the degree to which differences can be observed in other models of dopamine (DA) receptor activation has not been elucidated. The present study tested the effects of apomorphine, amphetamine, 8-OH-DPAT, and PCP on PPI in the Sprague Dawley and Wistar rat strains. Because apomorphine disrupts PPI via activation of DA receptors in the nucleus accumbens, apomorphine-induced hyperlocomotion, also a behavioral model of nucleus accumbens DA receptor activation, was measured in both rat strains. Administration of PCP or 8-OH-DPAT attenuated PPI in both strains, whereas apomorphine and amphetamine only attenuated PPI in Wistar rats. The ability of apomorphine to increase motor activity in the absence of a startle-eliciting stimulus was similar in the two strains, as was apomorphine-induced hyperlocomotion. A time course analysis of the effects of apomorphine on startle response in Sprague Dawley rats found that changes in the magnitude of PPI followed changes in basic startle amplitude. Similarly, no apomorphine-induced attenuation of PPI was observed in Sprague Dawley rats after 6-OHDA-induced DA receptor supersensitivity in the nucleus accumbens. These data suggest a dissociation between the effects of DA receptor agonists in PPI and other behavioral models of DA receptor activation.  (+info)

Effects of sustained phencyclidine exposure on sensorimotor gating of startle in rats. (6/421)

Phencyclidine (PCP), a non-competitive NMDA antagonist with actions at multiple other central nervous system receptors, can cause both acute and lasting psychoses in humans, and has also been used in cross-species models of psychosis. Acute exposure to PCP in rats produces behavioral changes, including a loss of prepulse inhibition (PPI) of the startle reflex, which parallels the loss of PPI observed in schizophrenia patients. Sustained exposure to PCP in rats produces neuropathological changes in several limbic regions and prolonged behavioral abnormalities that may parallel neuropsychological deficits in schizophrenia. It is unclear whether sustained PCP exposure will also produce a loss of prepulse inhibition which parallels the decrease observed in schizophrenia patients. In the present study, we examined changes in PPI during and after sustained PCP administration, using 5-day PCP exposure via subcutaneous osmotic minipumps, or 14-day PCP exposure via repeated intraperitoneal injections. In both forms of drug delivery, PPI was disrupted during, but not after, sustained drug exposure. PPI does not appear to be sensitive to neuropathological effects of sustained PCP exposure.  (+info)

Excitatory actions of NMDA receptor antagonists in rat entorhinal cortex and cultured entorhinal cortical neurons. (7/421)

We have characterized excitatory effects of non-competitive NMDA receptor antagonists MK-801, PCP, and ketamine in the rat entorhinal cortex and in cultured primary entorhinal cortical neurons using expression of immediate early gene c-fos as an indicator. NMDA receptor antagonists produced a strong and dose-dependent increase in c-fos mRNA and protein expression confined to neurons in the layer III of the caudal entorhinal cortex. Induction of c-fos mRNA is delayed and it is inhibited by antipsychotic drugs. Cultured entorhinal neurons are killed by high doses of MK-801 and PCP but c-fos expression is not induced in these neurons indicating that this in vitro model does not fully replicate the in vivo effects of PCP-like drugs in the entorhinal cortex. Excitatory effects of the NMDA receptor antagonists may be connected with the psychotropic side effects of these drugs and might become a useful model system to investigate neurobiology of psychosis.  (+info)

Characterization of interaction of 3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester with Torpedo californica nicotinic acetylcholine receptor and 5-hydroxytryptamine3 receptor. (8/421)

The widely used calcium channel antagonist 3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester (TMB-8) has been identified as a noncompetitive antagonist (NCA) and open-channel blocker of both muscle- and neuronal-type nicotinic acetylcholine receptors (AChRs). To further examine the interaction of TMB-8 with the AChR, the compound was tested as a competitor for the binding of two NCAs of the Torpedo californica AChR, phencyclidine and 3-trifluoromethyl-3-(m[125I]iodophenyl)diazirine, for which the binding to the AChR has been pharmacologically well characterized and a channel binding loci has been established. TMB-8 fully inhibited specific photoincorporation of 3-trifluoromethyl-3-(m[125I]iodophenyl)diazirine into the resting AChR channel (IC50 = 3.1 microM) and inhibited high-affinity [3H]phencyclidine binding to the desensitized AChR (IC50 = 2.4 microM). We conclude that TMB-8 is a potent NCA of the nicotinic AChR, interacting with the resting, open-channel, and desensitized channel conformations. TMB-8 was next tested as an inhibitor of the structurally homologous 5-hydroxytryptamine (5-HT)3 receptor (5-HT3R). Using 5-HT3R containing Sf21 cell membranes, TMB-8 completely inhibited specific binding of the radiolabeled 5-HT3R antagonist [3H]GR65630 (Ki = 2.5 microM). Furthermore, TMB-8 antagonized 5-HT-evoked currents of both mouse and human 5-HT3Rs expressed in Xenopus laevis oocytes, and additional analysis was consistent with a competitive antagonistic mechanism of action. These results, taken together, indicate that TMB-8 antagonizes the function of the AChR and 5-HT3R by different mechanisms. Given the sequence similarity and emerging evidence of structural homology in the channels of these two receptors, these results underscore the existence of subtle yet important structural differences in each channel.  (+info)

Phencyclidine (PCP) is a dissociative drug that was originally developed as an intravenous anesthetic in the 1950s. It can lead to distortions of time, space and body image, hallucinations, and a sense of physical invulnerability.

It can also cause numbness, loss of coordination, and aggressive behavior. High doses can lead to seizures, coma, and death. Long-term use can lead to memory loss, difficulties with speech and thinking, and mental health issues such as depression and suicidal thoughts. It is classified as a Schedule II drug in the United States, indicating it has a high potential for abuse but also an accepted medical use.

Phencyclidine (PCP) receptors refer to the specific binding sites in the brain and central nervous system where the drug phencyclidine exerts its pharmacological effects. PCP is an N-methyl-D-aspartate (NMDA) receptor antagonist, which means it blocks the action of the neurotransmitter glutamate at the NMDA receptors. These receptors are involved in learning, memory, and perception of pain.

PCP also interacts with other types of receptors, including sigma receptors, dopamine receptors, and muscarinic acetylcholine receptors, which contributes to its psychoactive effects. The drug's ability to cause dissociative states, hallucinations, and changes in perception is thought to be due to its antagonism of NMDA receptors, while its stimulant and euphoric effects are attributed to its interaction with dopamine receptors.

Overall, the binding of PCP to these various receptors results in a complex set of effects that can include altered mood, perception, and cognition, as well as potentially dangerous physical symptoms such as increased heart rate, blood pressure, and body temperature.

Phencyclidine (PCP) is a dissociative drug, which means it alters perception, thoughts, and feelings. It can cause hallucinations and a distorted sense of time, place, and reality. PCP abuse refers to the use of this substance in a manner that is not medically indicated and/or in a way that is harmful to the individual or others. This could include using PCP more frequently or in larger quantities than intended, continuing to use PCP despite negative consequences, or experiencing cravings or withdrawal symptoms when not using PCP. It's important to note that PCP abuse can lead to serious health issues, both physical and psychological, and can be addictive.

Hallucinogens are a class of psychoactive substances that alter perception, mood, and thought, often causing hallucinations, which are profound distortions in a person's perceptions of reality. These substances work by disrupting the normal functioning of the brain, particularly the parts that regulate mood, sensory perception, sleep, hunger, and sexual behavior.

Hallucinogens can be found in various forms, including plants, mushrooms, and synthetic compounds. Some common examples of hallucinogens include LSD (d-lysergic acid diethylamide), psilocybin (found in certain species of mushrooms), DMT (dimethyltryptamine), and ayahuasca (a plant-based brew from South America).

The effects of hallucinogens can vary widely depending on the specific substance, the dose, the individual's personality, mood, and expectations, and the environment in which the drug is taken. These effects can range from pleasant sensory experiences and heightened emotional awareness to terrifying hallucinations and overwhelming feelings of anxiety or despair.

It's important to note that hallucinogens can be dangerous, particularly when taken in high doses or in combination with other substances. They can also cause long-term psychological distress and may trigger underlying mental health conditions. As such, they should only be used under the guidance of a trained medical professional for therapeutic purposes.

Phenazocine is a synthetic opioid analgesic, which is primarily used for the treatment of moderate to severe pain. It is a schedule II controlled substance in the United States due to its high potential for abuse and addiction. Phenazocine works by binding to the mu-opioid receptors in the brain and spinal cord, which are responsible for mediating pain perception, reward, and addictive behaviors.

The medical definition of Phenazocine is:

A potent opioid analgesic with a rapid onset of action and a duration of effect of 2-4 hours. It is approximately ten times more potent than morphine and has similar side effects, including respiratory depression, sedation, nausea, vomiting, and constipation. Phenazocine is used for the management of acute pain, cancer pain, and as an adjunct in anesthesia. It is available in oral and injectable forms and may be administered intravenously, intramuscularly, or subcutaneously.

It's important to note that Phenazocine should only be used under the supervision of a qualified medical professional due to its potential for addiction and abuse.

Dizocilpine maleate is a chemical compound that is commonly known as an N-methyl-D-aspartate (NMDA) receptor antagonist. It is primarily used in research settings to study the role of NMDA receptors in various physiological processes, including learning and memory.

The chemical formula for dizocilpine maleate is C16H24Cl2N2O4·C4H4O4. The compound is a white crystalline powder that is soluble in water and alcohol. It has potent psychoactive effects and has been investigated as a potential treatment for various neurological and psychiatric disorders, although it has not been approved for clinical use.

Dizocilpine maleate works by blocking the action of glutamate, a neurotransmitter that plays a key role in learning and memory, at NMDA receptors in the brain. By doing so, it can alter various cognitive processes and has been shown to have anticonvulsant, analgesic, and neuroprotective effects in animal studies. However, its use is associated with significant side effects, including hallucinations, delusions, and memory impairment, which have limited its development as a therapeutic agent.

Excitatory amino acid antagonists are a class of drugs that block the action of excitatory neurotransmitters, particularly glutamate and aspartate, in the brain. These drugs work by binding to and blocking the receptors for these neurotransmitters, thereby reducing their ability to stimulate neurons and produce an excitatory response.

Excitatory amino acid antagonists have been studied for their potential therapeutic benefits in a variety of neurological conditions, including stroke, epilepsy, traumatic brain injury, and neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease. However, their use is limited by the fact that blocking excitatory neurotransmission can also have negative effects on cognitive function and memory.

There are several types of excitatory amino acid receptors, including N-methyl-D-aspartate (NMDA), alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), and kainite receptors. Different excitatory amino acid antagonists may target one or more of these receptor subtypes, depending on their specific mechanism of action.

Examples of excitatory amino acid antagonists include ketamine, memantine, and dextromethorphan. These drugs have been used in clinical practice for various indications, such as anesthesia, sedation, and treatment of neurological disorders. However, their use must be carefully monitored due to potential side effects and risks associated with blocking excitatory neurotransmission.

Clozapine is an atypical antipsychotic medication that is primarily used to treat schizophrenia in patients who have not responded to other antipsychotic treatments. It is also used off-label for the treatment of severe aggression, suicidal ideation, and self-injurious behavior in individuals with developmental disorders.

Clozapine works by blocking dopamine receptors in the brain, particularly the D4 receptor, which is thought to be involved in the development of schizophrenia. It also has a strong affinity for serotonin receptors, which contributes to its unique therapeutic profile.

Clozapine is considered a medication of last resort due to its potential side effects, which can include agranulocytosis (a severe decrease in white blood cell count), myocarditis (inflammation of the heart muscle), seizures, orthostatic hypotension (low blood pressure upon standing), and weight gain. Because of these risks, patients taking clozapine must undergo regular monitoring of their blood counts and other vital signs.

Despite its potential side effects, clozapine is often effective in treating treatment-resistant schizophrenia and has been shown to reduce the risk of suicide in some patients. It is available in tablet and orally disintegrating tablet formulations.

Amphibian venoms are toxic secretions produced by certain species of amphibians, such as frogs, toads, and salamanders. These secretions are often produced by specialized glands in the skin and can contain a variety of bioactive compounds, including alkaloids, steroids, peptides, and proteins. Some amphibian venoms can cause painful burns or irritation upon contact with the skin, while others can be deadly if ingested or introduced into the bloodstream through wounds or mucous membranes.

The study of amphibian venoms has gained increasing attention in recent years due to their potential as sources of novel bioactive compounds with therapeutic applications. For example, some peptides found in amphibian venoms have been shown to have potent analgesic, anti-inflammatory, and antimicrobial properties, making them promising candidates for the development of new drugs.

It is important to note that not all amphibians produce venom, and even those that do may use their toxic secretions primarily for defense against predators rather than for hunting prey. Additionally, while some amphibian venoms can be dangerous or even lethal to humans, most cases of envenomation occur in the context of intentional handling or accidental contact with these animals in their natural habitats.

Dibenzocycloheptenes are a class of chemical compounds that contain a dibenzocycloheptene moiety, which is a seven-membered ring with two benzene rings fused on either side. This structure gives the molecule a unique set of physical and chemical properties, including its aromaticity and reactivity.

In medical terms, dibenzocycloheptenes are not commonly used as therapeutic agents themselves. However, some derivatives of this class of compounds have been investigated for their potential medicinal properties. For example, certain dibenzocycloheptene derivatives have been shown to have anti-inflammatory, analgesic, and antipyretic effects, making them potentially useful as drugs for treating pain and inflammation.

It's important to note that while some dibenzocycloheptene derivatives may have potential therapeutic uses, they can also have side effects and risks, just like any other medication. Therefore, it's essential to consult with a healthcare professional before using any medication containing this or any other active ingredient.

Sigma receptors are a type of cell surface receptor that were initially thought to be opioid receptors but later found to have a distinct pharmacology. They are a heterogeneous group of proteins that are widely distributed in the brain and other tissues, where they play a role in various physiological functions such as neurotransmission, signal transduction, and modulation of ion channels.

Sigma receptors can be divided into two subtypes: sigma-1 and sigma-2. Sigma-1 receptors are ligand-regulated chaperone proteins that are localized in the endoplasmic reticulum (ER) and mitochondria-associated ER membranes, where they modulate calcium signaling, protein folding, and stress responses. Sigma-2 receptors, on the other hand, are still poorly characterized and their endogenous ligands and physiological functions remain elusive.

Sigma receptors can be activated by a variety of drugs, including certain antidepressants, neuroleptics, psychostimulants, and hallucinogens, as well as some natural compounds such as steroids and phenolamines. The activation of sigma receptors has been implicated in various neurological and psychiatric disorders, such as schizophrenia, depression, anxiety, addiction, pain, and neurodegeneration, although their exact role and therapeutic potential are still under investigation.

Dextroamphetamine is a central nervous system stimulant that is used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It works by increasing the levels of certain neurotransmitters, such as dopamine and norepinephrine, in the brain. Dextroamphetamine is available as a prescription medication and is sold under various brand names, including Adderall and Dexedrine. It is important to use this medication only as directed by a healthcare professional, as it can have potentially serious side effects if used improperly.

Neurotransmitter receptors are specialized protein molecules found on the surface of neurons and other cells in the body. They play a crucial role in chemical communication within the nervous system by binding to specific neurotransmitters, which are chemicals that transmit signals across the synapse (the tiny gap between two neurons).

When a neurotransmitter binds to its corresponding receptor, it triggers a series of biochemical events that can either excite or inhibit the activity of the target neuron. This interaction helps regulate various physiological processes, including mood, cognition, movement, and sensation.

Neurotransmitter receptors can be classified into two main categories based on their mechanism of action: ionotropic and metabotropic receptors. Ionotropic receptors are ligand-gated ion channels that directly allow ions to flow through the cell membrane upon neurotransmitter binding, leading to rapid changes in neuronal excitability. In contrast, metabotropic receptors are linked to G proteins and second messenger systems, which modulate various intracellular signaling pathways more slowly.

Examples of neurotransmitters include glutamate, GABA (gamma-aminobutyric acid), dopamine, serotonin, acetylcholine, and norepinephrine, among others. Each neurotransmitter has its specific receptor types, which may have distinct functions and distributions within the nervous system. Understanding the roles of these receptors and their interactions with neurotransmitters is essential for developing therapeutic strategies to treat various neurological and psychiatric disorders.

Haloperidol is an antipsychotic medication, which is primarily used to treat schizophrenia and symptoms of psychosis, such as delusions, hallucinations, paranoia, or disordered thought. It may also be used to manage Tourette's disorder, tics, agitation, aggression, and hyperactivity in children with developmental disorders.

Haloperidol works by blocking the action of dopamine, a neurotransmitter in the brain, which helps to regulate mood and behavior. It is available in various forms, including tablets, liquid, and injectable solutions. The medication can cause side effects such as drowsiness, restlessness, muscle stiffness, and uncontrolled movements. In rare cases, it may also lead to more serious neurological side effects.

As with any medication, haloperidol should be taken under the supervision of a healthcare provider, who will consider the individual's medical history, current medications, and other factors before prescribing it.

N-Methyl-D-Aspartate (NMDA) receptors are a type of ionotropic glutamate receptor, which are found in the membranes of excitatory neurons in the central nervous system. They play a crucial role in synaptic plasticity, learning, and memory processes. NMDA receptors are ligand-gated channels that are permeable to calcium ions (Ca2+) and other cations.

NMDA receptors are composed of four subunits, which can be a combination of NR1, NR2A-D, and NR3A-B subunits. The binding of the neurotransmitter glutamate to the NR2 subunit and glycine to the NR1 subunit leads to the opening of the ion channel and the influx of Ca2+ ions.

NMDA receptors have a unique property in that they require both agonist binding and membrane depolarization for full activation, making them sensitive to changes in the electrical activity of the neuron. This property allows NMDA receptors to act as coincidence detectors, playing a critical role in synaptic plasticity and learning.

Abnormal functioning of NMDA receptors has been implicated in various neurological disorders, including Alzheimer's disease, Parkinson's disease, epilepsy, and chronic pain. Therefore, NMDA receptors are a common target for drug development in the treatment of these conditions.

Antipsychotic agents are a class of medications used to manage and treat psychosis, which includes symptoms such as delusions, hallucinations, paranoia, disordered thought processes, and agitated behavior. These drugs work by blocking the action of dopamine, a neurotransmitter in the brain that is believed to play a role in the development of psychotic symptoms. Antipsychotics can be broadly divided into two categories: first-generation antipsychotics (also known as typical antipsychotics) and second-generation antipsychotics (also known as atypical antipsychotics).

First-generation antipsychotics, such as chlorpromazine, haloperidol, and fluphenazine, were developed in the 1950s and have been widely used for several decades. They are generally effective in reducing positive symptoms of psychosis (such as hallucinations and delusions) but can cause significant side effects, including extrapyramidal symptoms (EPS), such as rigidity, tremors, and involuntary movements, as well as weight gain, sedation, and orthostatic hypotension.

Second-generation antipsychotics, such as clozapine, risperidone, olanzapine, quetiapine, and aripiprazole, were developed more recently and are considered to have a more favorable side effect profile than first-generation antipsychotics. They are generally effective in reducing both positive and negative symptoms of psychosis (such as apathy, anhedonia, and social withdrawal) and cause fewer EPS. However, they can still cause significant weight gain, metabolic disturbances, and sedation.

Antipsychotic agents are used to treat various psychiatric disorders, including schizophrenia, bipolar disorder, major depressive disorder with psychotic features, delusional disorder, and other conditions that involve psychosis or agitation. They can be administered orally, intramuscularly, or via long-acting injectable formulations. The choice of antipsychotic agent depends on the individual patient's needs, preferences, and response to treatment, as well as the potential for side effects. Regular monitoring of patients taking antipsychotics is essential to ensure their safety and effectiveness.

**Ketamine** is a dissociative anesthetic medication primarily used for starting and maintaining anesthesia. It can lead to a state of altered perception, hallucinations, sedation, and memory loss. Ketamine is also used as a pain reliever in patients with chronic pain conditions and during certain medical procedures due to its strong analgesic properties.

It is available as a generic drug and is also sold under various brand names, such as Ketalar, Ketanest, and Ketamine HCl. It can be administered intravenously, intramuscularly, orally, or as a nasal spray.

In addition to its medical uses, ketamine has been increasingly used off-label for the treatment of mood disorders like depression, anxiety, and post-traumatic stress disorder (PTSD), owing to its rapid antidepressant effects. However, more research is needed to fully understand its long-term benefits and risks in these applications.

It's important to note that ketamine can be abused recreationally due to its dissociative and hallucinogenic effects, which may lead to addiction and severe psychological distress. Therefore, it should only be used under the supervision of a medical professional.

A startle reaction is a natural, defensive response to an unexpected stimulus that is characterized by a sudden contraction of muscles, typically in the face, neck, and arms. It's a reflexive action that occurs involuntarily and is mediated by the brainstem. The startle reaction can be observed in many different species, including humans, and is thought to have evolved as a protective mechanism to help organisms respond quickly to potential threats. In addition to the muscle contraction, the startle response may also include other physiological changes such as an increase in heart rate and blood pressure.

Substance-induced psychosis is a type of psychosis that is caused by the use of drugs, alcohol, or other substances. The American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) defines substance/medication-induced psychotic disorder as follows:

A. Presence of one (or more) of the following symptoms:

1. Delusions.
2. Hallucinations.
3. Disorganized speech (e.g., frequent derailment or incoherence).

B. There is evidence from the history, physical examination, or laboratory findings that the disturbance is caused by the direct physiological effects of a substance (e.g., a drug of abuse, a medication) or a combination of substances.

C. The disturbance does not occur exclusively during the course of a delirium and is not better explained by a psychotic disorder that is not substance/medication-induced. The symptoms in Criterion A developed during or soon after substance intoxication or withdrawal, or after exposure to a medication.

D. The disturbance causes significant distress or impairment in social, occupational, or other important areas of functioning.

E. The disturbance is not better accounted for by another mental disorder (e.g., major depressive disorder, bipolar disorder).

It's important to note that the diagnosis of substance-induced psychosis requires a thorough medical and psychiatric evaluation to determine if the symptoms are caused by substance use or another underlying mental health condition.

Cyclazocine is a synthetic opioid drug that acts as a partial agonist at mu and kappa opioid receptors, and as an antagonist at delta opioid receptors. It has analgesic (pain-relieving) effects, but its use as an analgesic is limited due to its potential for abuse and the occurrence of unpleasant psychotomimetic side effects such as dysphoria, delusions, and hallucinations.

Cyclazocine was first synthesized in 1957 and has been studied for its potential use in the treatment of opioid addiction, but it is not currently approved for medical use in many countries, including the United States. It is classified as a Schedule I controlled substance in the US, indicating that it has a high potential for abuse and no accepted medical use.

The prefrontal cortex is the anterior (frontal) part of the frontal lobe in the brain, involved in higher-order cognitive processes such as planning complex cognitive behavior, personality expression, decision making, and moderating social behavior. It also plays a significant role in working memory and executive functions. The prefrontal cortex is divided into several subregions, each associated with specific cognitive and emotional functions. Damage to the prefrontal cortex can result in various impairments, including difficulties with planning, decision making, and social behavior regulation.

"Street drugs" is a colloquial term rather than medical jargon, but it generally refers to illegal substances or medications that are used without a prescription. These can include a wide variety of drugs such as marijuana, cocaine, heroin, methamphetamines, ecstasy, LSD, and many others. They are called "street drugs" because they are often bought and sold on the street or in clandestine settings, rather than through legitimate pharmacies or medical professionals. It's important to note that these substances can be highly dangerous and addictive, with serious short-term and long-term health consequences.

Pentobarbital is a barbiturate medication that is primarily used for its sedative and hypnotic effects in the treatment of insomnia, seizure disorders, and occasionally to treat severe agitation or delirium. It works by decreasing the activity of nerves in the brain, which produces a calming effect.

In addition to its medical uses, pentobarbital has been used for non-therapeutic purposes such as euthanasia and capital punishment due to its ability to cause respiratory depression and death when given in high doses. It is important to note that the use of pentobarbital for these purposes is highly regulated and restricted to licensed medical professionals in specific circumstances.

Like all barbiturates, pentobarbital has a high potential for abuse and addiction, and its use should be closely monitored by a healthcare provider. It can also cause serious side effects such as respiratory depression, decreased heart rate, and low blood pressure, especially when used in large doses or combined with other central nervous system depressants.

Saccharin is not a medical term, but it is a chemical compound that is widely used as an artificial sweetener. Medically speaking, saccharin is classified as an intense sugar substitute, meaning it is many times sweeter than sucrose (table sugar) but contributes little to no calories when added to food or drink.

Saccharin is often used by people with diabetes or those who are trying to reduce their calorie intake. It has been in use for over a century and has undergone extensive safety testing. The U.S. Food and Drug Administration (FDA) has classified saccharin as generally recognized as safe (GRAS), although it once required a warning label due to concerns about bladder cancer. However, subsequent research has largely dismissed this risk for most people, and the warning label is no longer required.

It's important to note that while saccharin and other artificial sweeteners can be helpful for some individuals, they should not be used as a replacement for a balanced diet and regular exercise. Additionally, excessive consumption of these sugar substitutes may have negative health consequences, such as altering gut bacteria or contributing to metabolic disorders.

Azirines are a class of heterocyclic organic compounds that contain a three-membered ring consisting of two carbon atoms and one nitrogen atom. The structure of azirines can be represented by the chemical formula C2H2NR, where R is a hydrogen atom or a functional group.

Azirines are highly strained molecules due to the small size of the ring, which makes them reactive and useful in organic synthesis. They can undergo various reactions, such as cycloaddition, to form larger and more complex molecules. Azirines have been found to exhibit biological activity and are being investigated for their potential use in medicinal chemistry.

It is important to note that azirines are not a medical term per se, but rather a chemical term used to describe a specific class of organic compounds.

Substance abuse detection refers to the process of identifying the use or misuse of psychoactive substances, such as alcohol, illicit drugs, or prescription medications, in an individual. This can be done through various methods, including:

1. Physical examination: A healthcare professional may look for signs of substance abuse, such as track marks, enlarged pupils, or unusual behavior.
2. Laboratory tests: Urine, blood, hair, or saliva samples can be analyzed to detect the presence of drugs or their metabolites. These tests can provide information about recent use (hours to days) or longer-term use (up to several months).
3. Self-report measures: Individuals may be asked to complete questionnaires or interviews about their substance use patterns and behaviors.
4. Observational assessments: In some cases, such as in a treatment setting, healthcare professionals may observe an individual's behavior over time to identify patterns of substance abuse.

Substance abuse detection is often used in clinical, workplace, or legal settings to assess individuals for potential substance use disorders, monitor treatment progress, or ensure compliance with laws or regulations.

Stereotyped behavior, in the context of medicine and psychology, refers to repetitive, rigid, and invariant patterns of behavior or movements that are purposeless and often non-functional. These behaviors are not goal-directed or spontaneous and typically do not change in response to environmental changes or social interactions.

Stereotypies can include a wide range of motor behaviors such as hand flapping, rocking, head banging, body spinning, self-biting, or complex sequences of movements. They are often seen in individuals with developmental disabilities, intellectual disabilities, autism spectrum disorder, and some mental health conditions.

Stereotyped behaviors can also be a result of substance abuse, neurological disorders, or brain injuries. In some cases, these behaviors may serve as a self-soothing mechanism or a way to cope with stress, anxiety, or boredom. However, they can also interfere with daily functioning and social interactions, and in severe cases, may cause physical harm to the individual.

Dioxolanes are a class of organic compounds that contain a five-membered ring consisting of two carbon atoms, one oxygen atom, and two adjacent oxygen or sulfur atoms. The general structure of dioxolane is C2O2S2 or C2O3. These compounds are often used in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds due to their high reactivity and ability to act as protecting groups for carbonyl functionalities. Dioxolanes can also be found naturally in some foods and plants.

Schizophrenia is a severe mental disorder characterized by disturbances in thought, perception, emotion, and behavior. It often includes hallucinations (usually hearing voices), delusions, paranoia, and disorganized speech and behavior. The onset of symptoms typically occurs in late adolescence or early adulthood. Schizophrenia is a complex, chronic condition that requires ongoing treatment and management. It significantly impairs social and occupational functioning, and it's often associated with reduced life expectancy due to comorbid medical conditions. The exact causes of schizophrenia are not fully understood, but research suggests that genetic, environmental, and neurodevelopmental factors play a role in its development.

Columbidae is the family that includes all pigeons and doves. According to the medical literature, there are no specific medical definitions associated with Columbidae. However, it's worth noting that some species of pigeons and doves are commonly kept as pets or used in research, and may be mentioned in medical contexts related to avian medicine, zoonoses (diseases transmissible from animals to humans), or public health concerns such as bird-related allergies.

A reinforcement schedule is a concept in behavioral psychology that refers to the timing and pattern of rewards or reinforcements provided in response to certain behaviors. It is used to shape, maintain, or strengthen specific behaviors in individuals. There are several types of reinforcement schedules, including:

1. **Fixed Ratio (FR):** A reward is given after a fixed number of responses. For example, a salesperson might receive a bonus for every 10 sales they make.
2. **Variable Ratio (VR):** A reward is given after an unpredictable number of responses. This schedule is commonly used in gambling, as the uncertainty of when a reward (winning) will occur keeps the individual engaged and motivated to continue the behavior.
3. **Fixed Interval (FI):** A reward is given after a fixed amount of time has passed since the last reward, regardless of the number of responses during that time. For example, an employee might receive a paycheck every two weeks, regardless of how many tasks they completed during that period.
4. **Variable Interval (VI):** A reward is given after an unpredictable amount of time has passed since the last reward, regardless of the number of responses during that time. This schedule can be observed in foraging behavior, where animals search for food at irregular intervals.
5. **Combined schedules:** Reinforcement schedules can also be combined to create more complex patterns, such as a fixed ratio followed by a variable interval (FR-VI) or a variable ratio followed by a fixed interval (VR-FI).

Understanding reinforcement schedules is essential for developing effective behavioral interventions in various settings, including healthcare, education, and rehabilitation.

I believe you may be mistaken when referring to "torpedo" in the context of medicine. The term "torpedo" is not typically used as a medical definition. Instead, it is a term that has various meanings in different fields such as physics, military, and anatomy (in relation to electric fishes).

However, if you are referring to the use of "torpedo" in the context of neuromuscular disorders, it may refer to a type of treatment called "neuromuscular electrical stimulation" or NMES. In this case, the term "torpedo" is used metaphorically to describe the electrical impulse that is delivered to the muscle to cause a contraction. This can be used as a therapeutic intervention for various neuromuscular conditions such as muscle weakness or paralysis.

If you have any further questions, please let me know and I will do my best to assist you!

"Motor activity" is a general term used in the field of medicine and neuroscience to refer to any kind of physical movement or action that is generated by the body's motor system. The motor system includes the brain, spinal cord, nerves, and muscles that work together to produce movements such as walking, talking, reaching for an object, or even subtle actions like moving your eyes.

Motor activity can be voluntary, meaning it is initiated intentionally by the individual, or involuntary, meaning it is triggered automatically by the nervous system without conscious control. Examples of voluntary motor activity include deliberately lifting your arm or kicking a ball, while examples of involuntary motor activity include heartbeat, digestion, and reflex actions like jerking your hand away from a hot stove.

Abnormalities in motor activity can be a sign of neurological or muscular disorders, such as Parkinson's disease, cerebral palsy, or multiple sclerosis. Assessment of motor activity is often used in the diagnosis and treatment of these conditions.

A dose-response relationship in the context of drugs refers to the changes in the effects or symptoms that occur as the dose of a drug is increased or decreased. Generally, as the dose of a drug is increased, the severity or intensity of its effects also increases. Conversely, as the dose is decreased, the effects of the drug become less severe or may disappear altogether.

The dose-response relationship is an important concept in pharmacology and toxicology because it helps to establish the safe and effective dosage range for a drug. By understanding how changes in the dose of a drug affect its therapeutic and adverse effects, healthcare providers can optimize treatment plans for their patients while minimizing the risk of harm.

The dose-response relationship is typically depicted as a curve that shows the relationship between the dose of a drug and its effect. The shape of the curve may vary depending on the drug and the specific effect being measured. Some drugs may have a steep dose-response curve, meaning that small changes in the dose can result in large differences in the effect. Other drugs may have a more gradual dose-response curve, where larger changes in the dose are needed to produce significant effects.

In addition to helping establish safe and effective dosages, the dose-response relationship is also used to evaluate the potential therapeutic benefits and risks of new drugs during clinical trials. By systematically testing different doses of a drug in controlled studies, researchers can identify the optimal dosage range for the drug and assess its safety and efficacy.

N-Methyl-D-Aspartate (NMDA) is not a medication but a type of receptor, specifically a glutamate receptor, found in the post-synaptic membrane in the central nervous system. Glutamate is a major excitatory neurotransmitter in the brain. NMDA receptors are involved in various functions such as synaptic plasticity, learning, and memory. They also play a role in certain neurological disorders like epilepsy, neurodegenerative diseases, and chronic pain.

NMDA receptors are named after N-Methyl-D-Aspartate, a synthetic analog of the amino acid aspartic acid, which is a selective agonist for this type of receptor. An agonist is a substance that binds to a receptor and causes a response similar to that of the natural ligand (in this case, glutamate).

Benzomorphans are a class of opioid drugs that have a chemical structure similar to morphine. They are synthetic compounds, meaning they are made in a laboratory and do not occur naturally. Benzomorphans include drugs such as pentazocine and phenazocine, which are used for pain relief and cough suppression. These drugs work by binding to opioid receptors in the brain and spinal cord, which helps to reduce the perception of pain and suppress coughing.

Benzomorphans have a unique chemical structure that differs from other opioids such as morphine or fentanyl. They are classified as "mixed agonist-antagonists," meaning they can act as both an agonist (a substance that binds to a receptor and activates it) and an antagonist (a substance that binds to a receptor but does not activate it, and may block the effects of other substances that do activate the receptor). This property makes benzomorphans useful for pain relief in certain situations, as they can provide pain relief without causing some of the side effects associated with other opioids, such as respiratory depression.

However, like all opioid drugs, benzomorphans carry a risk of addiction and dependence, and can cause serious harm or even death if taken in large doses or mixed with other substances that depress the central nervous system. It is important to use these medications only as directed by a healthcare provider and to follow their instructions carefully.

Sprague-Dawley rats are a strain of albino laboratory rats that are widely used in scientific research. They were first developed by researchers H.H. Sprague and R.C. Dawley in the early 20th century, and have since become one of the most commonly used rat strains in biomedical research due to their relatively large size, ease of handling, and consistent genetic background.

Sprague-Dawley rats are outbred, which means that they are genetically diverse and do not suffer from the same limitations as inbred strains, which can have reduced fertility and increased susceptibility to certain diseases. They are also characterized by their docile nature and low levels of aggression, making them easier to handle and study than some other rat strains.

These rats are used in a wide variety of research areas, including toxicology, pharmacology, nutrition, cancer, and behavioral studies. Because they are genetically diverse, Sprague-Dawley rats can be used to model a range of human diseases and conditions, making them an important tool in the development of new drugs and therapies.

'Animal behavior' refers to the actions or responses of animals to various stimuli, including their interactions with the environment and other individuals. It is the study of the actions of animals, whether they are instinctual, learned, or a combination of both. Animal behavior includes communication, mating, foraging, predator avoidance, and social organization, among other things. The scientific study of animal behavior is called ethology. This field seeks to understand the evolutionary basis for behaviors as well as their physiological and psychological mechanisms.

Ritanserin is a medication that belongs to the class of drugs known as serotonin antagonists. It works by blocking the action of serotonin, a neurotransmitter in the brain, which helps to reduce anxiety and improve mood. Ritanserin was initially developed for the treatment of depression and schizophrenia, but its development was discontinued due to its side effects.

The medical definition of Ritanserin is:

A piperazine derivative and a serotonin antagonist that has been used in the treatment of depression and schizophrenia. Its therapeutic effect is thought to be related to its ability to block the action of serotonin at 5HT2 receptors. However, development of ritanserin was discontinued due to its side effects, including orthostatic hypotension, dizziness, and sedation. It has also been studied for its potential in treating cocaine addiction and alcohol withdrawal syndrome.

Amphetamine is a central nervous system stimulant drug that works by increasing the levels of certain neurotransmitters (chemical messengers) in the brain, such as dopamine and norepinephrine. It is used medically to treat conditions such as attention deficit hyperactivity disorder (ADHD), narcolepsy, and obesity, due to its appetite-suppressing effects.

Amphetamines can be prescribed in various forms, including tablets, capsules, or liquids, and are available under several brand names, such as Adderall, Dexedrine, and Vyvanse. They are also known by their street names, such as speed, uppers, or wake-ups, and can be abused for their euphoric effects and ability to increase alertness, energy, and concentration.

Long-term use of amphetamines can lead to dependence, tolerance, and addiction, as well as serious health consequences, such as cardiovascular problems, mental health disorders, and malnutrition. It is essential to use amphetamines only under the supervision of a healthcare provider and follow their instructions carefully.

An Electric organ is a specialized electric tissue found in some groups of fish, most notably in the electric eels and electric rays. It consists of modified muscle or nerve cells called electrocytes, which are capable of generating and transmitting electrical signals. These organs are used for various purposes such as navigation, communication, and hunting. In electric eels, for example, the electric organ can generate powerful electric shocks to stun prey or defend against predators.

"Phencyclidine". www.drugbank.ca. Retrieved 28 January 2019. Martin D, Lodge D (October 1988). "Phencyclidine receptors and N- ... Scholia has a profile for phencyclidine (Q407324). Wikimedia Commons has media related to Phencyclidine. Erowid.org - PCP ... Drugs and Human Performance Fact Sheets on Phencyclidine Phencyclidine and Ketamine: A View From the Street-1981 article on the ... Phencyclidine is used for its ability to induce a dissociative state. Behavioral effects can vary by dosage. Low doses produce ...
This box: view edit Except where noted otherwise, data relate to Standard temperature and pressure. Reliability of data general note. ^a ^b ^c ^d ^e ^f ^g ^h CID 6468 from PubChem (Articles with short description, Short description matches Wikidata, PubChem ID (CID) not in Wikidata, Chemical data pages, Chemical data pages cleanup ...
Phencyclidine (PCP or angel dust) is available as a street drug. Dextromethorphan-based cough syrups (often labeled DXM) are ... 1959) reported that patients under anaesthesia due to either ketamine or phencyclidine were prone to purposeless movements and ... Despite some dissociatives, such as phencyclidine (PCP) possessing stimulating properties, most dissociatives seem to have a ... "Phencyclidine". Nature. 285 (5764): 355-6. Bibcode:1980Natur.285..355S. doi:10.1038/285355a0. PMID 7189825. S2CID 208653777. ...
Phencyclidine • PD-128,907 • PD-168,077 • PF-219,061 • Piribedil • Pramipexole • Propylnorapomorphine • Pukateine • Quinagolide ... Phencyclidine • Pipradrol Pyrrolidines: Diphenylprolinol • Methylenedioxypyrovalerone (MDPV) • Naphyrone • Prolintane • ...
"; "woola"); heroin ("moon rock"); and phencyclidine ("clicker"; "p-funk"; "spacebase"). Crack smoking ("hitting the pipe"; " ...
Itzhak Y, Kalir A, Sarne Y (July 1981). "On the opioid nature of phencyclidine and its 3-hydroxy derivative". European Journal ... Johnson N, Itzhak Y, Pasternak GW (June 1984). "Interaction of two phencyclidine opiate-like derivatives with 3H-opioid binding ... 3-Hydroxyphencyclidine (3-HO-PCP) is a dissociative of the arylcyclohexylamine class related to phencyclidine (PCP) that has ... Holsztynska EJ, Domino EF (1986). "Quantitation of phencyclidine, its metabolites, and derivatives by gas chromatography with ...
Giannini AJ, Loiselle RH, Giannini MC, Price WA (1985). "Phencyclidine and the dissociatives". Psychiatric Medicine. 3 (3): 197 ... Unlike the other well-known dissociatives phencyclidine (PCP) and dextromethorphan (DXM), ketamine is very short-acting. It ...
An analog of phencyclidine". Drug Metabolism and Disposition. 21 (1): 125-32. PMID 8095205. Cho AK, Hiramatsu M, Schmitz DA, ... is a psychoactive drug and research chemical of the arylcyclohexylamine chemical class related to phencyclidine (PCP) and ...
Binding to the phencyclidine and sigma 1 receptors". Journal of Medicinal Chemistry. 41 (4): 468-77. doi:10.1021/jm970059p. ... Phencyclidine (PCP) is believed to be the first arylcyclohexylamine with recognized anesthetic properties, but several ... Hajikhani R, Ahmadi A, Naderi N, Yaghoobi K, Shirazizand Z, Rezaee NM, Niknafs BN (2012). "Effect of phencyclidine derivatives ... Itzhak Y, Kalir A, Weissman BA, Cohen S (May 1981). "New analgesic drugs derived from phencyclidine". Journal of Medicinal ...
Although their primary mechanisms of action are as NMDA receptor antagonists, ketamine and phencyclidine are also SNDRIs and ... Wallach J, Brandt SD (2018). "Phencyclidine-Based New Psychoactive Substances". New Psychoactive Substances. Handbook of ... weak SNDRI action likely contributes to effects and abuse potential Phencyclidine (Sernyl) - discontinued anesthetic and ...
Nicholson KL, Hayes BA, Balster RL (September 1999). "Evaluation of the reinforcing properties and phencyclidine-like ... Price, William A.; Giannini, Matthew C.; Giannini, A. James (1984). "Antidotal Strategies in Phencyclidine Intoxication". The ... Common Dissociative Drugs Include: PCP (Phencyclidine). 117 (4): 46-7. PMC 1518731. PMID 18730832. American Psychiatric ... phencyclidine (PCP), dextromethorphan (DXM), and nitrous oxide. However, dissociation is also remarkably administered by ...
Wallach J, Brandt SD (2018). "Phencyclidine-Based New Psychoactive Substances". New Psychoactive Substances. Handbook of ...
Ogunbadeniyi AM, Adejare A (2002). "Syntheses of fluorinated phencyclidine analogs". Journal of Fluorine Chemistry. 114: 39-42 ... "Structure-activity relationship studies of phencyclidine derivatives in rats". The Journal of Pharmacology and Experimental ...
Wallach J, Brandt SD (2018). "Phencyclidine-Based New Psychoactive Substances". New Psychoactive Substances. Handbook of ... and a structural isomer of phencyclidine. 3-Methyl-PCP BTCP Deoxymethoxetamine Ephenidine MDPCP Wallach J, De Paoli G, Adejare ...
Hyperforin Phencyclidine Indatraline Dexanabinol Doggrell SA. "Tesofensine - a novel potent weight loss medicine. Evaluation of ...
Phencyclidine (a.k.a. PCP; partial agonist. Psychoactivity mainly due to NMDA antagonism) Quinpirole (Partial agonist of the D2 ...
Phencyclidine (PCP, angel dust) is first synthesized. Vladimir Vernadsky popularises the concept of the biosphere in a book (in ...
NEFA is a moderate affinity NMDA antagonist (IC50 = 0.51 μM). It is a structural analog of phencyclidine. It was first ... "Open channel block and alteration of N-methyl-D-aspartic acid receptor gating by an analog of phencyclidine". Biophysical ...
Bensinger, Peter (January 25, 1978). "Placement of Phencyclidine in Schedule II" (PDF). Isomer Design. Drug Enforcement ...
Stephen H. Langdon begins excavations in Jemdet Nasr, finding proto-cuneiform clay tablets (3100-2900 BCE). Phencyclidine (PCP ...
Phencyclidine's biochemical properties are still mostly unknown; however, its use has been associated with dissociation, ... Another class of hallucinogens, known as dissociatives, includes drugs such as ketamine, phencyclidine (PCP), and Salvia ...
Maddox VH, Godefroi EF, Parcell RF (March 1965). "The synthesis of phencyclidine and other 1-arylcyclohexylamines". Journal of ...
Hayes BA, Balster RL (October 1985). "Anticonvulsant properties of phencyclidine-like drugs in mice". European Journal of ... April 1992). "Analogues of the dioxolanes dexoxadrol and etoxadrol as potential phencyclidine-like agents. Synthesis and ... December 1988). "Synthesis, absolute configuration, and molecular modeling study of etoxadrol, a potent phencyclidine-like ... electrophilic affinity ligand for the phencyclidine-binding site". FEBS Letters. 238 (2): 369-74. doi:10.1016/0014-5793(88) ...
Phencyclidine Derivatives - A new Class of Designer Drugs. Studies on the Metabolism and Toxicological Analysis. Universität ... It is around the same potency as phencyclidine, although slightly less potent than its ethyl homologue eticyclidine, and has ... MADDOX VH, GODEFROI EF, PARCELL RF (March 1965). "The Synthesis of Phencyclidine and Other 1-Arylcyclohexylamines". Journal of ...
Giannini AJ, Bowman RK, Giannini JD (August 1999). "Perception of nonverbal facial cues in chronic phencyclidine abusers". ... These groups reported diminished receptive ability in heroin addicts and phencyclidine abusers, contrasted with increased ...
Tahir, Hassan; Daruwalla, Vistasp (2015). "Phencyclidine Induced Oculogyric Crisis Responding Well to Conventional Treatment". ... phencyclidine ("PCP"), reserpine, and cetirizine, an antihistamine. High-potency neuroleptics are the most common cause. Other ...
Phencyclidine may be a useful anaesthetic because it does not impact the cardiovascular center. This also contrasts ... phencyclidine from many other recreational drugs. Vasomotor center Wehrwein, Erica A.; Joyner, Michael J. (2013-01-01), Buijs, ...
Phencyclidine: a dissociative anesthetic previously used in medicine, but its development was discontinued in the 1960s in ... Rolicyclidine: a less potent analogue of phencyclidine, but seems to be seldom, if ever, abused. Sevoflurane: an inhalational ... Olney JW, Labruyere J, Price MT (June 1989). "Pathological changes induced in cerebrocortical neurons by phencyclidine and ... Eticyclidine: a slightly more potent dissociative anesthetic than phencyclidine but with greater nausea/unpleasant taste, that ...
... has been used in the illicit production of phencyclidine and its analogs and is often subject to purchase ... Shulgin, A. T.; MacLean, D. E. (25 September 2008). "Illicit Synthesis of Phencyclidine (PCP) and Several of Its Analogs". ...
Slifer BL, Balster RL, May EL (October 1986). "Reinforcing and phencyclidine-like stimulus properties of enantiomers of ... Shannon HE (July 1982). "Pharmacological analysis of the phencyclidine-like discriminative stimulus properties of narcotic ...
"Phencyclidine". www.drugbank.ca. Retrieved 28 January 2019. Martin D, Lodge D (October 1988). "Phencyclidine receptors and N- ... Scholia has a profile for phencyclidine (Q407324). Wikimedia Commons has media related to Phencyclidine. Erowid.org - PCP ... Drugs and Human Performance Fact Sheets on Phencyclidine Phencyclidine and Ketamine: A View From the Street-1981 article on the ... Phencyclidine is used for its ability to induce a dissociative state. Behavioral effects can vary by dosage. Low doses produce ...
Phencyclidine (PCP) was originally developed for use as a general anesthetic for surgery under the trade name Sernyl in the ... encoded search term (Phencyclidine Toxicity) and Phencyclidine Toxicity What to Read Next on Medscape ... Phencyclidine (PCP) was originally developed in the 1950s for use as a general anesthetic for surgery, under the trade name ... False positive phencyclidine results caused by venlafaxine. Am J Psychiatry. 2007 Feb. 164 (2):349. [QxMD MEDLINE Link]. ...
Phencyclidine (PCP, Angel Dust) is a cheap and popular drug often concentrated in selected socioeconomic groups. PCP may be ... Phencyclidine has several analogues and precursors. Most are illegal. Some labratories screen for phencyclidine by immunoassay ... Phencyclidine is rapidly absorbed from the lung and easily crosses the blood/brain barrier. In an average size (150 lb.) ... Phencyclidine (PCP, Angel Dust) is a cheap and popular drug often concentrated in selected socioeconomic groups. PCP may be ...
Munch JC Phencyclidine: pharmacology and toxicology Bulletin on Narcotics 1974 26(4):9-17 ... Phencyclidine (PCP) was introduced in 1960 as an analgesic and general anesthetic for man, but too many severe adverse effects ... "Phencyclidine: pharmacology and toxicology" Bulletin on Narcotics. 1974 Oct-Dec 21;26(4):9-17. ...
Seroquel restores sensorimotor gating in phencyclidine-treated rats.. N R Swerdlow, V Bakshi and M A Geyer ... Seroquel restores sensorimotor gating in phencyclidine-treated rats.. N R Swerdlow, V Bakshi and M A Geyer ... Seroquel restores sensorimotor gating in phencyclidine-treated rats.. N R Swerdlow, V Bakshi and M A Geyer ... Seroquel restores sensorimotor gating in phencyclidine-treated rats. Message Subject (Your Name) has forwarded a page to you ...
... the image of phencyclidine (PCP) in the popular media J Psychedelic Drugs 1980 12(3-4):195-204 ... "The dusting of America: the image of phencyclidine (PCP) in the popular media". ... "The dusting of America: the image of phencyclidine (PCP) in the popular media" J Psychedelic Drugs. 1980 Jul-Dec 26;12(3-4): ...
phencyclidine. P450. cytochrome P450. P4502B1. the major P450 form from liver microsomes of phenobarbital-treated rats. DLPC. l ... Metabolic Inactivation of Cytochrome P4502B1 by Phencyclidine. Uma Sharma, Elizabeth S. Roberts, Ute M. Kent, S. Michael Owens ... Metabolic Inactivation of Cytochrome P4502B1 by Phencyclidine. Uma Sharma, Elizabeth S. Roberts, Ute M. Kent, S. Michael Owens ... Metabolic Inactivation of Cytochrome P4502B1 by Phencyclidine Message Subject (Your Name) has forwarded a page to you from Drug ...
... the image of phencyclidine (PCP) in the popular media J Psychedelic Drugs 1980 12(3-4):195-204 ... "The dusting of America: the image of phencyclidine (PCP) in the popular media". ... "The dusting of America: the image of phencyclidine (PCP) in the popular media" J Psychedelic Drugs. 1980 Jul-Dec 26;12(3-4): ...
Patel A Phencyclidine intoxication and adverse effects: a clinical and pharmacological review of an illicit drug Cal J Emerg ... Phencyclidine (PCP, angel dust ) is an infamous hallucinogenic sought for its ability to induce the illusion of euphoria, ... "Phencyclidine intoxication and adverse effects: a clinical and pharmacological review of an illicit drug". ... "Phencyclidine intoxication and adverse effects: a clinical and pharmacological review of an illicit drug" Cal J Emerg Med ...
Video title: Phencyclidine Drug test - PCP Drug test. Category: Rapid test videos Views: 2,888. Submitted by: admin. ... Phencyclidine (PCP). Formats:. RapidDip™ Instatest - Strip. Any drug Any combination. RapiCard™ Instatest - Cassette Any drug ... Phencyclidine Drug test, PCP Drug test, Ketamine Drug test ... Phencyclidine Drug test - PCP Drug test. Rapidtest.com. * ...
MK-801 from pig N-methyl D-aspartate receptor phencyclidine binding site after 150 min by liquid scintillation counting method. ...
Methoxetamine is a dissociative drug belonging to the arylcyclohexylamine class including phencyclidine and ketamine thats sold ...
Los Angeles, Calif. : U.S. Dept. of Justice, Drug Enforcement Administration, Los Angeles Division, 1986. ...
What is Phencyclidine, and how does it look like? Phencyclidine is a bitter-tasting, white crystalline powder that detaches its ... Everything You Need to Know About Phencyclidine aka Angel Dust. Bob Edwards - August 23, 2021. 0 ...
PCP (Phencyclidine). Surgeons used PCP in the 1950s as a general anesthetic, but manufacturers stopped producing it due to its ... Phencyclidine [Fact sheet]. (2020).. https://www.deadiversion.usdoj.gov/drug_chem_info/pcp.pdf. ...
Buy Phencyclidine PCP Online Phencyclidine PCP Powder Online is a strong dissociative medication that was first created in the ...
For a Chapter 7 , 11 or 13 Bankruptcy or Foreclosure Attorney in Los Angeles please visit IBankruptcyAttorneys.com. For a divorce lawyer contact Divorcelawyerslosangeles.com. For a patent, copyright or trademark attorney visit patentattorneysdenver.com for a consultation with ellen reilly.. For a dui defense attorney in Los Angeles please visit https://criminaldefenseattorneylosangeles.com/dui-attorney/ to speak with a dui attorney.. For a San Diego DUI Defense Lawyer visitSevens Legal, APC - San Diego DUI Lawyers.. For domesticviolenceattorneysandiego.com click on the link before.. Do you need to appeal your federal criminal defense case? contact Pat Ford.. For a criminal law attorney or Best Criminal Defense Attorney Los Angeles call Daniel Perlman. For a San Diego DUI Defense Attorney or Criminal Defense Lawyer San Diego. For a San Diego Immigration Lawyer. For a Divorce Lawyer San Diego. For car accident and truck accident related personal injuries please visit our Los Angeles Personal ...
... is a lateral flow chromatographic immunoassay for the detection of Phencyclidine in Oral Fluid. ... The PCP One Step Phencyclidine Test (Oral Fluid) ... Home , Drugs of abuse , PCP One Step Phencyclidine Test (Oral ... Oral Fluid PCP test, saliva PCP test, Oral Fluid Phencyclidine test, saliva Phencyclidine test, Phencyclidine Test ... The PCP One Step Phencyclidine Test (Oral Fluid) is a lateral flow chromatographic immunoassay for the detection of ...
Buy Phencyclidine PCP Online Phencyclidine PCP Powder Online is a strong dissociative medication that was first created in the ... Home Products tagged "phencyclidine is commonly known as:". Showing the single result ...
Can Thyroid Medication Be Positive For Phencyclidine - Click here for more information. Find everything you need to know about ... FAQ Can Thyroid Medication Be Positive For Phencyclidine. How do I take the Thyroid Support supplement?. VitaPost recommends ... Can Thyroid Medication Be Positive For Phencyclidine. Extracts of herbs and fruits. *Schisandra powder (240mg). - Schisandra ... Can Thyroid Medication Be Positive For Phencyclidine. Shipping and Refund Policy. Thyroid Support orders come with a shipping ...
Ketamine and Phencyclidine (PCP) and Special Subjects - Learn about from the MSD Manuals - Medical Professional Version. ... Ketamine and phencyclidine (PCP) are chemically related anesthetics. These drugs are often used to adulterate or pass for other ... Ketamine and phencyclidine are N-methyl-D-aspartate receptor antagonists and dissociative anesthetics that can cause ... Users of ketamine and phencyclidine (PCP) should be kept in a quiet, calming environment and closely observed. Benzodiazepines ...
Phencyclidine (PCP, Angel Dust) is a cheap and popular drug often concentrated in selected socioeconomic groups. PCP may be ...
U batla sephutheloana se tšepahalang le se nepahetseng sa Phencyclidine (PCP) Rapid Test?Lihlahisoa tsa rona tsa Teko tsa ... Phencyclidine (PCP) Teko e potlakileng. Tlhaloso e Khutšoanyane:. Tlhahlobo e potlakileng ea Genfocus® Phencyclidine (PCP) ke. ... Phallo ea morao-rao, mohato o le mong oa immunoassay bakeng sa tlhahlobo ea boleng ba phencyclidine ka hara moroto oa motho. ... Hara lisampole tse 60 tse se nang phencyclidine kaofela li ile tsa khethoa hore li mpe.Ea lisampole (60) tse nang le. ...
Dive into the research topics of Recent advances in the phencyclidine model of schizophrenia. Together they form a unique ...
... find complete details about PCP Phencyclidine Rapid Test - Guangzhou Mandison Biotechnology Co.,ltd ...
Phencyclidine. 9106. METHAMPHETAMINE and Illicit Drugs, Precursors and Adulterants on Wipes by Liquid-Liquid Extraction. ... Phencyclidine. 9109. METHAMPHETAMINE and Illicit Drugs, Precursors and Adulterants on Wipes by Solid-Phase Extraction. ...
  • Ketamine and phencyclidine are N-methyl-D-aspartate receptor antagonists and dissociative anesthetics that can cause intoxication, sometimes with confusion or a catatonic state. (msdmanuals.com)
  • Ketamine and phencyclidine (PCP) are chemically related anesthetics. (msdmanuals.com)
  • Users of ketamine and phencyclidine (PCP) should be kept in a quiet, calming environment and closely observed. (msdmanuals.com)
  • The most common piperidines and piperazine are phencyclidine (PCP), ketamine and benzylpiperazine (BZP). (medscape.com)
  • [iii] Illicit drugs such as methamphetamine, phencyclidine (PCP) and cocaine accounted for 24% of these deaths. (cdc.gov)
  • Phencyclidine or phenylcyclohexyl piperidine (PCP), also known as angel dust among other names, is a dissociative anesthetic mainly used recreationally for its significant mind-altering effects. (wikipedia.org)
  • Phencyclidine is used for its ability to induce a dissociative state. (wikipedia.org)
  • Phencyclidine (PCP) is a hallucinogen-specifically, a dissociative anesthetic-that can produce a wide variety of physical and behavioral effects and has a high potential for abuse and dependence. (medscape.com)
  • Phencyclidine (PCP) is a dissociative hallucinogenic drug that was initially developed as a general anesthetic. (diamondrehabthailand.com)
  • Some labratories screen for phencyclidine by immunoassay and confirms by gas chromatography/mass spectrometry (GC/MS). (healthy.net)
  • The PCP One Step Phencyclidine Test (Oral Fluid) is a lateral flow chromatographic immunoassay for the detection of Phencyclidine in Oral Fluid. (aluxbio.com)
  • Phencyclidine (PCP, angel dust ) is an infamous hallucinogenic sought for its ability to induce the illusion of euphoria, omnipotence, superhuman strength, and social and sexual prowess. (erowid.org)
  • Phencyclidine (PCP) is a Schedule II substance with hallucinogenic effects and the potential for abuse and addiction. (diamondrehabthailand.com)
  • Phencyclidine (PCP) was originally developed in the 1950s for use as a general anesthetic for surgery, under the trade name Sernyl. (medscape.com)
  • In the 1950s, phencyclidine was investigated as an anesthetic but, due to the side efffects of confusion and delirium, its development for human use was discontinued. (druglibrary.net)
  • Bey T, Patel A. "Phencyclidine intoxication and adverse effects: a clinical and pharmacological review of an illicit drug" Cal J Emerg Med . (erowid.org)
  • Today, virtually all of the phencyclidine encountered on the illicit market in the United States is produced in clandestine laboratories. (druglibrary.net)
  • Seroquel restores sensorimotor gating in phencyclidine-treated rats. (aspetjournals.org)
  • 5. Carlezon, W.A. Jr. & Wise, R.A. Rewarding actions drug to its receptor, but rather by the rats, treatments associated with aversive of phencyclidine and related drugs in nucleus ac- failure of an expected drug injection to states such as severe drug withdrawal cumbens shell and frontal cortex. (lu.se)
  • Behavioural effects of neonatal lesions of the medial prefrontal cortex and subchronic pubertal treatment with phencyclidine of adult rats. (bvsalud.org)
  • Acute administration of the psychotomimetic phencyclidine (PCP) can mimic some features of schizophrenia, while a repeated treatment regimen of PCP may provide a more effective way to model in animals the enduring cognitive dysfunction observed in many schizophrenic patients. (brad.ac.uk)
  • "Phencyclidine: pharmacology and toxicology" Bulletin on Narcotics . (erowid.org)
  • Gerhardt, GA , Pang, K & Rose, GM 1987, ' In vivo electrochemical demonstration of the presynaptic actions of phencyclidine in rat caudate nucleus ', Journal of Pharmacology and Experimental Therapeutics , vol. 241, no. 2, pp. 714-721. (uky.edu)
  • Vickroy, TW & Johnson, KM 1982, ' Similar dopamine-releasing effects of phencyclidine and nonamphetamine stimulants in striatal slices ', Journal of Pharmacology and Experimental Therapeutics , vol. 233, no. 3, pp. 669-674. (utmb.edu)
  • Phencyclidine (PCP) elicits some behavioral and biochemical effects in rodents which resemble the effects of other central nervous system stimulants. (utmb.edu)
  • When the histamine (HA) turnover in the brain of mice was estimated on the basis of the pargyline-induced accumulation of tele-methylhistamine (t-MH), a predominant metabolite of brain HA, the enhancing effect of phencyclidine (PCP) on the HA turnover was antagonized by a large dose of naloxone. (elsevierpure.com)
  • Phencyclidine (PCP) was introduced in 1960 as an analgesic and general anesthetic for man, but too many severe adverse effects developed, including hallucinations, manic depressive and schizophrenic-like symptoms. (erowid.org)
  • Long-term phencyclidine effects range from speech difficulties and memory problems to anxiety and depression, social withdrawal, suicidal thoughts, and flashbacks. (diamondrehabthailand.com)
  • What are Phencyclidine (PCP) short-term health effects? (diamondrehabthailand.com)
  • Phencyclidine, more commonly known as PCP, is illicitly marketed under a number of other names including Angel Dust, Supergrass, Killer Weed, Embalming Fluid, and Rocket Fuel, reflecting the range of its bizarre and volatile effects. (druglibrary.net)
  • Phencyclidine (PCP, Angel Dust) is a cheap and popular drug often concentrated in selected socioeconomic groups. (healthy.net)
  • In 1978, due to considerable abuse of phencyclidine, it was transferred to Schedule II of the CSA and manufacturing of Sernylan was discontinued. (druglibrary.net)
  • Rose, G. M. / In vivo electrochemical demonstration of the presynaptic actions of phencyclidine in rat caudate nucleus . (uky.edu)
  • Lysergic acid diethylamide (LSD) is a classic hallucinogen, widely abused for decades, while phencyclidine (PCP) has increased in popularity in recent years, especially among the adolescents. (imi.hr)
  • The acute toxicity of phencyclidine (PCP) is often misdiagnosed because of its similarity to schizophrenic episodes. (medscape.com)
  • Urine phencyclidine drug tests can detect up to weeks after the use and hair phencyclidine drug tests can detect up to 90 days after the consumption of the drug. (gomdnow.com)
  • Ketamine and phencyclidine are chemically similar drugs used for anesthesia but are sometimes used recreationally. (msdmanuals.com)
  • The predominant member of this class is phencyclidine (PCP), a derivative of the anaesthetic ketamine. (erowid.org)
  • We previously reported that phencyclidine (PCP), an NMDA receptor antagonist, increased locomotor activity in wildtype (WT) mice but not GluN2D subunit knockout mice. (biomedcentral.com)
  • We have investigated that effects of phencyclidine (PCP) on [ 3 H]-spiperone binding to synaptic membrane in the presence of sulpiride to distinguish serotonin (5-HT 2 ) receptor from dopamine 2 receptor. (fujita-hu.ac.jp)
  • Administration of the N-methyl-D-aspartate (NMDA) antagonist phencyclidine (PCP) may produce alterations in behavior that resemble those that have been observed in animal models of schizophrenia. (utmb.edu)
  • however, the agitation that some people developed following phencyclidine-induced anesthesia quickly led to its abandonment for this indication. (medscape.com)
  • The range of medical effects and complications resulting from excessive use of drugs of abuse like phencyclidine (PCP) has hindered the development of effective medications. (aspetjournals.org)
  • The ability of these compounds to bind in vitro to dopaminergic, serotoninergic, phencyclidine (PCP) and sigma binding sites will be investigated. (nih.gov)
  • Phencyclidine (PCP) abuse usually causes a short, self-limited period of intoxication but may lead to a prolonged psychosis, poorly responsive to antipsychotic medications. (northwestern.edu)
  • Identifying signs and symptoms of phencyclidine abuse can help in taking appropriate actions. (gomdnow.com)
  • Acute phencyclidine intoxication: clinical patterns, complications, and treatment. (medscape.com)
  • Phencyclidine or PCP for short is a synthetic drug with stimulant and hallucinogenic properties. (homehealth-uk.com)
  • Phencyclidine (PCP) drug tests are diagnostic tools used to detect the presence of PCP or its metabolites in an individual's system. (gomdnow.com)
  • Budai B, Iskandar H. Dextromethorphan can produce false positive phencyclidine testing with HPLC. (medscape.com)
  • Phencyclidine was used for a time as an animal anesthetic, but even this use has ceased in the United States. (medscape.com)
  • Available at http://www.samhsa.gov/data/sites/default/files/DAWN143/DAWN143/sr143-emergency-phencyclidine-2013.pdf . (medscape.com)
  • A single case of phencyclidine use has been reported in which a small amount of phencyclidine was detected in breastmilk over 6 weeks after use of an unknown quantity of the drug. (nih.gov)